# FDA MEMO - Novo Nordisk A/S - March 25, 2024

Source: https://www.globalkeysolutions.net/records/memo/novo-nordisk-as/c64eef41-5e75-4ec1-8077-7d00df21947b

> FDA MEMO for Novo Nordisk A/S on March 25, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: MEMO
- Company Name: Novo Nordisk A/S
- Inspection Date: 2024-03-25
- Product Type: drugs
- Office Name: Office of Pharmaceutical Manufacturing Assessment

## Related Documents

- [483 - 2024-03-25](https://www.globalkeysolutions.net/records/483/novo-nordisk-as/da5518cf-dd42-4d5b-b2f7-bdbb6dd3182c)
- [EIR - 2024-03-25](https://www.globalkeysolutions.net/records/eir/novo-nordisk-as/e5940682-7d77-485a-a366-11b1f33ca5dc)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-manufacturing-assessment/fe47b0bd-c1c6-4458-a8c9-15e4b073d3df